HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yohei Miyamoto Selected Research

vitamin K1 oxide

9/2017Pharmacological effects of a vitamin K1 2,3-epoxide reductase (VKOR) inhibitor, 3-acetyl-5-methyltetronic acid, on cisplatin-induced fibrosis in rats.
7/2012A novel vitamin K1 2,3-epoxide reductase (VKOR) inhibitor, 3-acetyl-5-methyltetronic acid, reduces experimental glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yohei Miyamoto Research Topics

Disease

7Pruritus (Itching)
01/2022 - 05/2010
7Glomerulonephritis
09/2017 - 04/2005
5Chronic Renal Insufficiency
01/2017 - 04/2011
4Fibrosis (Cirrhosis)
09/2017 - 08/2007
2Liver Diseases (Liver Disease)
01/2022 - 01/2016
2Neuralgia (Stump Neuralgia)
01/2019 - 11/2010
2Familial Primary Pulmonary Hypertension
02/2017 - 10/2008
2Renal Insufficiency (Renal Failure)
08/2008 - 02/2004
1Hypertension (High Blood Pressure)
01/2018
1Lymphoma (Lymphomas)
09/2017
1Neoplasms (Cancer)
09/2017
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
02/2017
1Breast Neoplasms (Breast Cancer)
02/2017
1Body Weight (Weight, Body)
01/2017
1Hypertrophy
04/2016
1Cardiovascular Diseases (Cardiovascular Disease)
02/2015
1Hyperuricemia
01/2015
1Proteinuria
01/2015
1Diabetic Nephropathies (Diabetic Nephropathy)
07/2013
1Acute Kidney Injury (Acute Renal Failure)
11/2012
1Crohn Disease (Crohn's Disease)
10/2011
1Autoimmune Diseases (Autoimmune Disease)
10/2011
1Substance-Related Disorders (Drug Abuse)
11/2010
1Pain (Aches)
11/2010
1Dyskinesias (Dyskinesia)
11/2010
1Schizophrenia (Dementia Praecox)
11/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2010
1Drug-Related Side Effects and Adverse Reactions
12/2009

Drug/Important Bio-Agent (IBA)

6TRK 820IBA
01/2022 - 05/2010
5Pharmaceutical PreparationsIBA
01/2022 - 10/2008
4AntipruriticsIBA
10/2016 - 11/2010
4Biomarkers (Surrogate Marker)IBA
11/2013 - 10/2011
3Proteins (Proteins, Gene)FDA Link
02/2017 - 12/2009
3OsteopontinIBA
11/2013 - 11/2012
3Cystatin CIBA
11/2013 - 11/2012
3CalbindinsIBA
11/2013 - 11/2012
3ClusterinIBA
11/2013 - 11/2012
3Epidermal Growth Factor (EGF)IBA
11/2013 - 11/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013 - 11/2012
2AntioxidantsIBA
01/2018 - 01/2015
2BenzbromaroneIBA
01/2018 - 01/2015
23-acetyl-5-methyltetronic acidIBA
09/2017 - 07/2012
2Oxidoreductases (Dehydrogenase)IBA
09/2017 - 07/2012
2vitamin K1 oxideIBA
09/2017 - 07/2012
2Cisplatin (Platino)FDA LinkGeneric
09/2017 - 08/2007
2Vitamin KFDA Link
09/2017 - 05/2008
2beraprostIBA
02/2017 - 10/2008
2Epoprostenol (Prostacyclin)FDA LinkGeneric
02/2017 - 10/2008
2Opioid Analgesics (Opioids)IBA
10/2016 - 07/2012
2Phenobarbital (Luminal)FDA Link
04/2016 - 07/2009
2Sulfates (Sulfates, Inorganic)IBA
02/2015 - 04/2013
2CreatinineIBA
01/2015 - 11/2013
2NitrogenIBA
01/2015 - 07/2009
2Urea (Carbamide)FDA LinkGeneric
01/2015 - 07/2009
2Lipocalin-2IBA
11/2013 - 07/2013
2Glutathione Transferase (Glutathione S-Transferase)IBA
11/2013 - 07/2013
2Metalloproteases (Metalloproteinases)IBA
11/2013 - 07/2013
2CytokinesIBA
04/2013 - 09/2011
2Catechin (Z 7300)IBA
08/2008 - 02/2004
2gallocatechol (epigallocatechin)IBA
08/2008 - 02/2004
2TeaIBA
08/2008 - 02/2004
1imidazoleIBA
01/2019
1piperidineIBA
01/2019
1Angiotensin IIIBA
01/2018
1SaltsIBA
01/2018
1anti-Thy antibodyIBA
09/2017
1Organic Cation Transporter 1IBA
02/2017
1Member 11 Subfamily B ATP Binding Cassette TransporterIBA
02/2017
1Organic Cation Transporter 2IBA
02/2017
1Multidrug Resistance-Associated Protein 2IBA
02/2017
1AnionsIBA
02/2017
1Peptides (Polypeptides)IBA
02/2017
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2017
1Organic Anion TransportersIBA
02/2017
1TabletsIBA
01/2017
1EnzymesIBA
04/2016
1LipidsIBA
04/2016
1Hematoxylin (Haematoxylon)IBA
04/2016
1Eosine Yellowish-(YS) (Eosin)IBA
04/2016
1ClofibrateFDA Link
04/2016
1furanIBA
01/2016
1IsoenzymesIBA
01/2015
1antiglomerular basement membrane antibodyIBA
11/2013
1Biological ProductsIBA
04/2013
1Messenger RNA (mRNA)IBA
04/2013
1NADPH Oxidases (NAD(P)H oxidase)IBA
04/2013
1Alanine Transaminase (SGPT)IBA
10/2011
1doramapimodIBA
10/2011
1p38 Mitogen-Activated Protein KinasesIBA
10/2011
1Uremic ToxinsIBA
09/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2011
1IndicanIBA
04/2011
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
11/2010
1Naltrexone (ReVia)FDA LinkGeneric
09/2010
1Narcotic Antagonists (Opioid Antagonists)IBA
09/2010
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
02/2010
1DNA (Deoxyribonucleic Acid)IBA
02/2010

Therapy/Procedure

6Renal Dialysis (Hemodialysis)
01/2022 - 05/2010
3Oral Administration
01/2018 - 05/2008
1Peritoneal Dialysis
01/2022